Standalone revenue projections 2025E/2026E
Company: Core Scientific
The claim, verbatim
Core Scientific's standalone plan projects total revenue of $389.4 million in 2025E and $916.7 million in 2026E, with CoreWeave-related revenue ~76% of 2026E total and ~95% of colocation revenue.
Source (primary)
core-scientific 8-K exhibit (ef20057150_ex99-1.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-09-28)Live source ↗
Quote: “By 2026E, CoreWeave-related revenue is projected to constitute ~95% of Core Scientific's Colocation revenue and ~76% of its total projected revenue”
How we checked this
Checked on September 30, 2026. The cited source supports every part of this claim.
The deck's standalone revenue projections chart shows totals of $389.4 (2025E) and $916.7 (2026E). The accompanying text gives the ~95% colocation and ~76% total CoreWeave-related shares for 2026E.
Confirmed in the source:
- Core Scientific's standalone plan projects total revenue of $389.4 million in 2025E
- Core Scientific's standalone plan projects total revenue of $916.7 million in 2026E
- CoreWeave-related revenue is projected at ~76% of Core Scientific's 2026E total revenue
- CoreWeave-related revenue is projected at ~95% of Core Scientific's 2026E colocation revenue
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000114036125038207/ef20057150_ex99-1.htm) in full (42,945 characters, retrieved September 28, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (ef20057150_ex99-1.htm)
Quote: “By 2026E, CoreWeave-related revenue is projected to constitute ~95% of Core Scientific's Colocation revenue and ~76% of its total projected revenue”